Drug Shortage Report for FLUMAZENIL INJECTION

Last updated on 2021-12-06

Report ID 146649
Drug Identification Number 02249561
Brand name FLUMAZENIL INJECTION
Common or Proper name FLUMAZENIL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FLUMAZENIL
Strength(s) 0.1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ML10LIVI
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-10-04
Estimated end date 2021-12-10
Actual end date 2021-12-06
Shortage status Resolved
Updated date 2021-12-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-12-06 French Compare
v7 2021-12-06 English Compare
v6 2021-11-08 French Compare
v5 2021-11-08 English Compare
v4 2021-10-14 French Compare
v3 2021-10-14 English Compare
v2 2021-10-04 French Compare
v1 2021-10-04 English Compare

Showing 1 to 8 of 8